%PDF-1.2 
%âãÏÓ
 
12 0 obj
<<
/Length 13 0 R
>>
stream
BT
304.56 74.88  TD
0 0 0 rg 
/F0 12  Tf
0  Tc 0  Tw (i) Tj
-59.76 635.28  TD /F1 12  Tf
(TABLE OF CONTENTS) Tj
-172.8 -25.68  TD /F2 12  Tf
(TABLE OF AUTHORITIES. . . . . . . . . . . . . . . . . . . . . .ii ) Tj
0 -25.44  TD (INTRODUCTION) Tj
100.8 0  TD 7.2  Tc (........................) Tj
0  Tc (.) Tj
360 0  TD (1) Tj
-460.8 -25.44  TD (I.  INTEREST AND EXPERTISE OF THE FEDERAL TRADE COMMISSION) Tj
432 0  TD 7.2  Tc (.) Tj
0  Tc (.) Tj
28.8 0  TD (1) Tj
-460.8 -25.44  TD (II.  BACKGROUND) Tj
115.2 0  TD 7.2  Tc (.......................) Tj
0  Tc (.) Tj
345.6 0  TD (4) Tj
-424.8 -25.44  TD (A.  Generic Drug Entry Into the Marketplace) Tj
324 0  TD 7.2  Tc (......) Tj
0  Tc (.) Tj
100.8 0  TD (4) Tj
-424.8 -25.44  TD (B.  Hatch-Waxman Act) Tj
151.2 0  TD 7.2  Tc (..................) Tj
0  Tc (.) Tj
273.6 0  TD (6) Tj
-460.8 -25.44  TD (III.  POTENTIAL COMPETITIVE IMPACT OF THE PROPOSED SETTLEMENT) Tj
453.6 0  TD (10) Tj
-453.6 -25.44  TD (IV.  CONCLUSION) Tj
115.2 0  TD 7.2  Tc (......................) Tj
0  Tc (.) Tj
338.4 0  TD (13) Tj
ET
endstream
endobj
13 0 obj
1059
endobj
4 0 obj
<<
/Type /Page
/Parent 5 0 R
/Resources <<
/Font <<
/F0 6 0 R 
/F1 8 0 R 
/F2 10 0 R 
>>
/ProcSet 2 0 R
>>
/Contents 12 0 R
>>
endobj
17 0 obj
<<
/Length 18 0 R
>>
stream
BT
303.12 74.88  TD
0 0 0 rg 
/F0 12  Tf
0  Tc 0  Tw (ii) Tj
-72.72 645.84  TD /F1 12  Tf
(TABLE OF AUTHORITIES ) Tj
-158.4 -38.88  TD (CASES) Tj
36 0  TD /F2 12  Tf
( ) Tj
396 0  TD /F1 12  Tf
(PAGE) Tj
28.8 0  TD /F2 12  Tf
( ) Tj
-460.8 -27.12  TD /F3 12  Tf
(Abbott Laboratories v. Novopharm Ltd.) Tj
266.4 0  TD /F2 12  Tf
(,) Tj
-230.4 -12.72  TD (104 F.3d 1305 \(Fed. Cir. 1997\)) Tj
223.2 0  TD (...........................) Tj
201.6 0  TD (9) Tj
-460.8 -26.16  TD /F3 12  Tf
(Ben Venue Laboratories, Inc. v. Novartis Pharmaceutical Corp.) Tj
439.2 0  TD /F2 12  Tf
(,) Tj
-403.2 -12.72  TD (10 F. Supp. 2d 446 \(D.N.J. 1998\)) Tj
237.6 0  TD (..................) Tj
136.8 0  TD (7, 9, 10) Tj
-410.4 -26.16  TD /F3 12  Tf
(Bristol-Myers Squibb Co. v. Ben Venue Laboratories) Tj
360 0  TD /F2 12  Tf
(,) Tj
-324 -12.72  TD (90 F. Supp. 2d 522 \(D.N.J. 2000\)) Tj
237.6 0  TD (.........................) Tj
187.2 0  TD (6) Tj
-460.8 -26.16  TD /F3 12  Tf
(Ciba-Geigy, Ltd.) Tj
115.2 0  TD /F2 12  Tf
(,) Tj
-79.2 -12.72  TD (123 F.T.C. 842 \(1997\)) Tj
158.4 0  TD (....................................) Tj
266.4 0  TD (2) Tj
-460.8 -26.16  TD /F3 12  Tf
(Â鶹´«Ã½ Trade Commission v. Mylan Laboratories, Inc. et al.) Tj
424.8 0  TD /F2 12  Tf
(,) Tj
-388.8 -12.72  TD (1999-2 Trade Cas. \(CCH\) \26672,573 \(D.D.C. 1999\)) Tj
331.2 0  TD (............) Tj
93.6 0  TD (2) Tj
-460.8 -26.88  TD /F3 12  Tf
(Geneva Pharmaceuticals, Inc.) Tj
201.6 0  TD /F2 12  Tf
(, C-3946 \(May 26, 2000\) ) Tj
-165.6 -12.72  TD (\(FTC consent order\)) Tj
144 0  TD (......................................) Tj
280.8 0  TD (4) Tj
-460.8 -26.16  TD /F3 12  Tf
(Hoechst AG) Tj
72 0  TD /F2 12  Tf
(,) Tj
-36 -12.72  TD (120 F.T.C. 1010 \(1995\)) Tj
165.6 0  TD (...................................) Tj
259.2 0  TD (2) Tj
-460.8 -26.88  TD /F3 12  Tf
(Purdue Pharma. L.P. v. Boehringer Ingelheim, GmbH) Tj
352.8 0  TD /F2 12  Tf
(, ) Tj
-316.8 -12.72  TD (2000 Lexis 6563 \(S.D.N.Y. 2000\)) Tj
230.4 0  TD (..........................) Tj
194.4 0  TD (9) Tj
-460.8 -26.16  TD /F3 12  Tf
(Rite-Hite Corp. v. Kelley Co.) Tj
208.8 0  TD /F2 12  Tf
(,) Tj
-172.8 -12.72  TD (56 F.3d 1538 \(Fed. Cir. 1995\)) Tj
216 0  TD (............................) Tj
208.8 0  TD (8) Tj
-460.8 -26.88  TD /F3 12  Tf
(Roche Holding Ltd.) Tj
129.6 0  TD /F2 12  Tf
(, C-3809 \(February 25, 1998\) ) Tj
-93.6 -12.72  TD (\(FTC consent order\)) Tj
144 0  TD (......................................) Tj
280.8 0  TD (2) Tj
-460.8 -39.36  TD /F1 12  Tf
(FEDERAL STATUTES ) Tj
0 -25.68  TD /F2 12  Tf
(Â鶹´«Ã½ Trade Commission Act) Tj
36 -25.44  TD (15 U.S.C. \247 45) Tj
108 0  TD (...........................................) Tj
316.8 0  TD (1) Tj
-460.8 -25.44  TD (Food and Drug Administration) Tj
36 -25.44  TD (21 U.S.C. \247 355\(a\)) Tj
136.8 0  TD (.......................................) Tj
288 0  TD (6) Tj
-424.8 -25.44  TD (21 U.S.C. \247 355\(b\)\(1\)) Tj
158.4 0  TD (....................................) Tj
266.4 0  TD (7) Tj
ET
endstream
endobj
18 0 obj
3004
endobj
14 0 obj
<<
/Type /Page
/Parent 5 0 R
/Resources <<
/Font <<
/F0 6 0 R 
/F1 8 0 R 
/F2 10 0 R 
/F3 15 0 R 
>>
/ProcSet 2 0 R
>>
/Contents 17 0 R
>>
endobj
20 0 obj
<<
/Length 21 0 R
>>
stream
BT
301.68 74.88  TD
0 0 0 rg 
/F0 12  Tf
0  Tc 0  Tw (iii) Tj
-193.68 659.76  TD /F2 12  Tf
(21 U.S.C. \247 355\(c\)\(2\)) Tj
158.4 0  TD (...................................) Tj
259.2 0  TD (10) Tj
-417.6 -25.44  TD (21 U.S.C. \247 355\(j\)\(5\)\(B\)\(iv\)) Tj
208.8 0  TD (.............................) Tj
216 0  TD (3) Tj
-460.8 -25.44  TD (Patent) Tj
36 -25.44  TD (35 U.S.C. \247 271\(e\)\(1\)) Tj
158.4 0  TD (....................................) Tj
266.4 0  TD (8) Tj
-460.8 -39.36  TD /F1 12  Tf
(REGULATIONS) Tj
36 -25.68  TD /F2 12  Tf
(21 C.F.R. \247 314.53\(b\)) Tj
158.4 0  TD (................................) Tj
237.6 0  TD (7, 10) Tj
-396 -25.44  TD (21 C.F.R. \247 314.53\(f\)) Tj
158.4 0  TD (...................................) Tj
259.2 0  TD (10) Tj
-453.6 -25.44  TD (     21 C.F.R. \247 314.94) Tj
172.8 0  TD (.......................................) Tj
288 0  TD (8) Tj
-460.8 -38.64  TD /F1 12  Tf
(MISCELLANEOUS ) Tj
0 -26.4  TD /F2 12  Tf
(Congressional Budget Office, ) Tj
208.8 0  TD /F3 12  Tf
(How Increased Competition from) Tj
-172.8 -13.44  TD (Generic Drugs Has Affected Prices and Returns in the) Tj
0 -13.44  TD (Pharmaceutical Industry) Tj
165.6 0  TD /F2 12  Tf
( \(July 1998\)) Tj
93.6 0  TD (......................) Tj
165.6 0  TD (5) Tj
-460.8 -25.44  TD (David A. Balto & James Mongoven, Antitrust Â鶹´«Ã½ in) Tj
36 -12.72  TD (Pharmaceutical Industry Mergers,) Tj
0 -13.44  TD (54 ) Tj
21.6 0  TD /F3 12  Tf
(Food & Drug Law Journal) Tj
165.6 0  TD /F2 12  Tf
(, 255 \(1999\)) Tj
93.6 0  TD (...................) Tj
144 0  TD (2) Tj
-460.8 -25.44  TD (Elizabeth Dickinson, "FDA's Role in Making Exclusivity) Tj
36 -13.44  TD (Determinations," 54 ) Tj
144 0  TD /F3 12  Tf
(Food & Drug L.J.) Tj
115.2 0  TD /F2 12  Tf
(, 195, 196 \(1999\)) Tj
129.6 0  TD (...) Tj
28.8 0  TD (10) Tj
-222.72 -52.8  TD /F0 12  Tf
(  ) Tj
ET
endstream
endobj
21 0 obj
1874
endobj
19 0 obj
<<
/Type /Page
/Parent 5 0 R
/Resources <<
/Font <<
/F0 6 0 R 
/F1 8 0 R 
/F2 10 0 R 
/F3 15 0 R 
>>
/ProcSet 2 0 R
>>
/Contents 20 0 R
>>
endobj
6 0 obj
<<
/Type /Font
/Subtype /TrueType
/Name /F0
/BaseFont /TimesNewRoman
/FirstChar 32
/LastChar 255
/Widths [ 260 320 400 500 500 840 760 160 340 340 500 560 260 340 260 280 
500 500 500 500 500 500 500 500 500 500 280 260 560 560 560 420 
900 700 660 660 720 620 540 720 720 340 380 700 600 880 720 720 
560 720 660 560 620 720 720 920 720 720 600 340 280 340 460 500 
320 440 480 440 500 440 300 500 480 240 240 500 240 740 480 520 
500 500 340 380 300 500 480 720 480 460 440 480 200 480 540 780 
560 780 560 560 560 560 560 560 560 560 560 560 560 780 560 780 
780 560 560 560 560 560 560 560 560 560 560 560 560 780 560 560 
260 320 500 500 500 500 200 500 320 760 260 480 560 340 760 500 
380 540 300 280 300 580 440 260 300 300 320 480 760 760 760 400 
700 700 700 700 700 700 900 660 620 620 620 620 340 340 340 340 
720 720 720 720 720 720 720 560 720 720 720 720 720 720 560 520 
440 440 440 440 440 440 660 440 440 440 440 440 240 240 240 240 
500 480 520 520 520 520 520 540 500 500 500 500 500 460 500 460 
]
/Encoding /WinAnsiEncoding
/FontDescriptor 7 0 R
>>
endobj
7 0 obj
<<
/Type /FontDescriptor
/FontName /TimesNewRoman
/Flags 34
/FontBBox [ -250 -216 1104 1040 ]
/MissingWidth 340
/StemV 73
/StemH 73
/ItalicAngle 0
/CapHeight 891
/XHeight 446
/Ascent 891
/Descent -216
/Leading 149
/MaxWidth 920
/AvgWidth 401
>>
endobj
8 0 obj
<<
/Type /Font
/Subtype /TrueType
/Name /F1
/BaseFont /CourierNew,Bold
/FirstChar 32
/LastChar 255
/Widths [ 600 600 600 600 600 600 600 600 600 600 600 600 600 600 600 600 
600 600 600 600 600 600 600 600 600 600 600 600 600 600 600 600 
600 600 600 600 600 600 600 600 600 600 600 600 600 600 600 600 
600 600 600 600 600 600 600 600 600 600 600 600 600 600 600 600 
600 600 600 600 600 600 600 600 600 600 600 600 600 600 600 600 
600 600 600 600 600 600 600 600 600 600 600 600 600 600 600 600 
600 600 600 600 600 600 600 600 600 600 600 600 600 600 600 600 
600 600 600 600 600 600 600 600 600 600 600 600 600 600 600 600 
600 600 600 600 600 600 600 600 600 600 600 600 600 600 600 600 
600 600 600 600 600 600 600 600 600 600 600 600 600 600 600 600 
600 600 600 600 600 600 600 600 600 600 600 600 600 600 600 600 
600 600 600 600 600 600 600 600 600 600 600 600 600 600 600 600 
600 600 600 600 600 600 600 600 600 600 600 600 600 600 600 600 
600 600 600 600 600 600 600 600 600 600 600 600 600 600 600 600 
]
/Encoding /WinAnsiEncoding
/FontDescriptor 9 0 R
>>
endobj
9 0 obj
<<
/Type /FontDescriptor
/FontName /CourierNew,Bold
/Flags 16418
/FontBBox [ -250 -300 720 1000 ]
/MissingWidth 600
/StemV 191
/StemH 191
/ItalicAngle 0
/CapHeight 833
/XHeight 417
/Ascent 833
/Descent -300
/Leading 133
/MaxWidth 600
/AvgWidth 600
>>
endobj
10 0 obj
<<
/Type /Font
/Subtype /TrueType
/Name /F2
/BaseFont /CourierNew
/FirstChar 32
/LastChar 255
/Widths [ 600 600 600 600 600 600 600 600 600 600 600 600 600 600 600 600 
600 600 600 600 600 600 600 600 600 600 600 600 600 600 600 600 
600 600 600 600 600 600 600 600 600 600 600 600 600 600 600 600 
600 600 600 600 600 600 600 600 600 600 600 600 600 600 600 600 
600 600 600 600 600 600 600 600 600 600 600 600 600 600 600 600 
600 600 600 600 600 600 600 600 600 600 600 600 600 600 600 600 
600 600 600 600 600 600 600 600 600 600 600 600 600 600 600 600 
600 600 600 600 600 600 600 600 600 600 600 600 600 600 600 600 
600 600 600 600 600 600 600 600 600 600 600 600 600 600 600 600 
600 600 600 600 600 600 600 600 600 600 600 600 600 600 600 600 
600 600 600 600 600 600 600 600 600 600 600 600 600 600 600 600 
600 600 600 600 600 600 600 600 600 600 600 600 600 600 600 600 
600 600 600 600 600 600 600 600 600 600 600 600 600 600 600 600 
600 600 600 600 600 600 600 600 600 600 600 600 600 600 600 600 
]
/Encoding /WinAnsiEncoding
/FontDescriptor 11 0 R
>>
endobj
11 0 obj
<<
/Type /FontDescriptor
/FontName /CourierNew
/Flags 34
/FontBBox [ -250 -300 720 1000 ]
/MissingWidth 600
/StemV 109
/StemH 109
/ItalicAngle 0
/CapHeight 833
/XHeight 417
/Ascent 833
/Descent -300
/Leading 133
/MaxWidth 600
/AvgWidth 600
>>
endobj
15 0 obj
<<
/Type /Font
/Subtype /TrueType
/Name /F3
/BaseFont /CourierNew,Italic
/FirstChar 32
/LastChar 255
/Widths [ 600 600 600 600 600 600 600 600 600 600 600 600 600 600 600 600 
600 600 600 600 600 600 600 600 600 600 600 600 600 600 600 600 
600 600 600 600 600 600 600 600 600 600 600 600 600 600 600 600 
600 600 600 600 600 600 600 600 600 600 600 600 600 600 600 600 
600 600 600 600 600 600 600 600 600 600 600 600 600 600 600 600 
600 600 600 600 600 600 600 600 600 600 600 600 600 600 600 600 
600 600 600 600 600 600 600 600 600 600 600 600 600 600 600 600 
600 600 600 600 600 600 600 600 600 600 600 600 600 600 600 600 
600 600 600 600 600 600 600 600 600 600 600 600 600 600 600 600 
600 600 600 600 600 600 600 600 600 600 600 600 600 600 600 600 
600 600 600 600 600 600 600 600 600 600 600 600 600 600 600 600 
600 600 600 600 600 600 600 600 600 600 600 600 600 600 600 600 
600 600 600 600 600 600 600 600 600 600 600 600 600 600 600 600 
600 600 600 600 600 600 600 600 600 600 600 600 600 600 600 600 
]
/Encoding /WinAnsiEncoding
/FontDescriptor 16 0 R
>>
endobj
16 0 obj
<<
/Type /FontDescriptor
/FontName /CourierNew,Italic
/Flags 98
/FontBBox [ -250 -300 720 1000 ]
/MissingWidth 600
/StemV 109
/StemH 109
/ItalicAngle -11
/CapHeight 833
/XHeight 417
/Ascent 833
/Descent -300
/Leading 133
/MaxWidth 600
/AvgWidth 600
>>
endobj
2 0 obj
[ /PDF /Text  ]
endobj
5 0 obj
<<
/Kids [4 0 R 14 0 R 19 0 R ]
/Count 3
/Type /Pages
/MediaBox [ 0 0 612 792 ]
>>
endobj
1 0 obj
<<
/Creator ()
/CreationDate (D:20000907150659)
/Title (D:\webstuff\2000\September 7\taxol br.toc-toa.wpd)
/Author (JDIBLASI)
/Producer (Acrobat PDFWriter 3.02 for Windows NT)
/Keywords ()
/Subject ()
>>
endobj
3 0 obj
<<
/Pages 5 0 R
/Type /Catalog
>>
endobj
xref
0 22
0000000000 65535 f 
0000012169 00000 n 
0000012040 00000 n 
0000012388 00000 n 
0000001154 00000 n 
0000012071 00000 n 
0000006636 00000 n 
0000007722 00000 n 
0000007982 00000 n 
0000009070 00000 n 
0000009336 00000 n 
0000010421 00000 n 
0000000019 00000 n 
0000001133 00000 n 
0000004376 00000 n 
0000010680 00000 n 
0000011772 00000 n 
0000001296 00000 n 
0000004355 00000 n 
0000006481 00000 n 
0000004531 00000 n 
0000006460 00000 n 
trailer
<<
/Size 22
/Root 3 0 R
/Info 1 0 R
/ID [<820ed19585351edec955f49bd035e355><820ed19585351edec955f49bd035e355>]
>>
startxref
12437
%%EOF